METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
People with metastatic castration-resistant prostate CANCER are asked to participate in a research study being conducted by Montefiore Medical Center.
You may be eligible to participate in this study if you:
- Are a male ≥18 years of age
- Have histologically or cytologically confirmed adenocarcinoma of the prostate without pure small cell carcinoma
- Adequate organ, bone marrow, and hepatic function
You may NOT participate in this study if you:
- Are currently receiving treatment in another study
- Have participated in a study of an investigational agent or an investigational device within 4 weeks of first dose of study therapy
- Have received radiation therapy or major surgery within 14 days of first administration of study drug
- Have received any previous systemic biologic therapy
- Have known immunodeficiency virus (HIV) infection, hepatitis B or C
- Have a receipt of a live vaccine within 4 weeks of planned start of study medication
Contact Information
Mary Portes, Study Coordinator
1695 Eastchester Rd, 5th floor Room # 503,
Bronx, NY-10461
Phone: (718) 405-8427
Email: MPORTES@MONTEFIORE.ORG